Literature DB >> 15640285

HMGB1 contributes to the development of acute lung injury after hemorrhage.

Jae Yeol Kim1, Jong Sung Park, Derek Strassheim, Ivor Douglas, Fernando Diaz del Valle, Karim Asehnoune, Sanchayita Mitra, Sang Hyun Kwak, Shingo Yamada, Ikuro Maruyama, Akitoshi Ishizaka, Edward Abraham.   

Abstract

High mobility group box 1 (HMGB1) is a novel late mediator of inflammatory responses that contributes to endotoxin-induced acute lung injury and sepsis-associated lethality. Although acute lung injury is a frequent complication of severe blood loss, the contribution of HMGB1 to organ system dysfunction in this setting has not been investigated. In this study, HMGB1 was detected in pulmonary endothelial cells and macrophages under baseline conditions. After hemorrhage, in addition to positively staining endothelial cells and macrophages, neutrophils expressing HMGB1 were present in the lungs. HMGB1 expression in the lung was found to be increased within 4 h of hemorrhage and then remained elevated for more than 72 h after blood loss. Neutrophils appeared to contribute to the increase in posthemorrhage pulmonary HMGB1 expression since no change in lung HMGB1 levels was found after hemorrhage in mice made neutropenic with cyclophosphamide. Plasma concentrations of HMGB1 also increased after hemorrhage. Blockade of HMGB1 by administration of anti-HMGB1 antibodies prevented hemorrhage-induced increases in nuclear translocation of NF-kappa B in the lungs and pulmonary levels of proinflammatory cytokines, including keratinocyte-derived chemokine, IL-6, and IL-1 beta. Similarly, both the accumulation of neutrophils in the lung as well as enhanced lung permeability were reduced when anti-HMGB1 antibodies were injected after hemorrhage. These results demonstrate that hemorrhage results in increased HMGB1 expression in the lungs, primarily through neutrophil sources, and that HMGB1 participates in hemorrhage-induced acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640285     DOI: 10.1152/ajplung.00359.2004

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  111 in total

1.  Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation.

Authors:  Te I Weng; Hsiao Yi Wu; Chia Wei Kuo; Shing Hwa Liu
Journal:  Intensive Care Med       Date:  2011-01-29       Impact factor: 17.440

2.  Immunomodulatory drugs regulate HMGB1 release from activated human monocytes.

Authors:  Hanna Schierbeck; Heidi Wähämaa; Ulf Andersson; Helena Erlandsson Harris
Journal:  Mol Med       Date:  2010-04-09       Impact factor: 6.354

3.  Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis.

Authors:  Minghua Yang; Lizhi Cao; Min Xie; Yan Yu; Rui Kang; Liangchun Yang; Mingyi Zhao; Daolin Tang
Journal:  Biochem Pharmacol       Date:  2013-05-22       Impact factor: 5.858

Review 4.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 5.  Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer.

Authors:  Geetha Srikrishna; Hudson H Freeze
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

6.  Neutrophils counteract autophagy-mediated anti-inflammatory mechanisms in alveolar macrophage: role in posthemorrhagic shock acute lung inflammation.

Authors:  Zongmei Wen; Liyan Fan; Yuehua Li; Zui Zou; Melanie J Scott; Guozhi Xiao; Song Li; Timothy R Billiar; Mark A Wilson; Xueyin Shi; Jie Fan
Journal:  J Immunol       Date:  2014-09-29       Impact factor: 5.422

7.  Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo.

Authors:  Forrest Jessop; Andrij Holian
Journal:  Nanotoxicology       Date:  2014-07-01       Impact factor: 5.913

8.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192

9.  Functional roles for C5a receptors in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Brian A Nadeau; Danielle E Day; Markus Huber-Lang; Charles R Mackay; Firas S Zetoune; Norma P Gerard; Katherine Cianflone; Jörg Köhl; Craig Gerard; J Vidya Sarma; Peter A Ward
Journal:  Nat Med       Date:  2008-05-04       Impact factor: 53.440

10.  Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity.

Authors:  Ayumi Yoshizaki; Kazuhiro Komura; Yohei Iwata; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Shinichi Sato
Journal:  J Clin Immunol       Date:  2008-09-30       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.